000 01388 a2200385 4500
005 20250514162043.0
264 0 _c20040816
008 200408s 0 0 eng d
022 _a1534-4827
024 7 _a10.1007/s11892-003-0007-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBierhaus, Angelika
245 0 0 _aNew treatments for diabetic neuropathy: pathogenetically oriented treatment.
_h[electronic resource]
260 _bCurrent diabetes reports
_cDec 2003
300 _a452-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aDiabetic Neuropathies
_xpathology
650 0 4 _aDiabetic Retinopathy
_xphysiopathology
650 0 4 _aEndothelium, Vascular
_xphysiopathology
650 0 4 _aGlycation End Products, Advanced
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLipolysis
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aOxidative Stress
_xphysiology
650 0 4 _aPolymers
_xmetabolism
650 0 4 _aProtein Kinase C
_xmetabolism
700 1 _aHumpert, Per M
700 1 _aRudofsky, Gottfried
700 1 _aWendt, Thoralf
700 1 _aMorcos, Michael
700 1 _aHamann, Andreas
700 1 _aNawroth, Peter P
773 0 _tCurrent diabetes reports
_gvol. 3
_gno. 6
_gp. 452-8
856 4 0 _uhttps://doi.org/10.1007/s11892-003-0007-z
_zAvailable from publisher's website
999 _c14349068
_d14349068